Inhibition of PAF-induced human platelet responses by newly synthesized ether phospholipids

This publication has 13 references indexed in Scilit:

• Effectiveness and tolerability of CV-3988, a selective PAF antagonist, after intravenous administration to man.
  British Journal of Clinical Pharmacology, 1988
• Proaggregatory and inhibitory effects of 2-O-ethyl analogues of platelet-activating factor (PAF) on human and rabbit platelets
  Thrombosis Research, 1988
• Phase I trial of the thioether phospholipid analogue BM 41.440 in cancer patients
  Lipids, 1987
• PAF-acether specific binding sites: 1. quantitative SAR study of PAF-acether isosteres
  Trends in Pharmacological Sciences, 1986
• Synthesis of ether phospholipids
  Pharmacological Research Communications, 1986
• PLATELET ACTIVATING FACTOR: A BIOLOGICALLY ACTIVE PHOSPHOGLYCERIDE
  Annual Review of Biochemistry, 1986
• PAF-acether specific binding sites: 2. Design of specific antagonists
  Trends in Pharmacological Sciences, 1986
• Cytotoxicity of platelet activating factor and related alkyl- phospholipid analogs in human leukemia cells, polymorphonuclear neutrophils, and skin fibroblasts
  Blood, 1984
• Early tumor and leukemia response to alkyl-lysophospholipids in a phase I study
  Cancer, 1982
• A facile method for the preparation of 1-O-alkyl-2-O-acetoyl-sn-glycero-3-phosphocholines (platelet activating factor)
  Chemistry and Physics of Lipids, 1981